ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.33
-0.75%
US Tech 100
17,336.80
-2.40%
S&P 500
5,158.20
-2.36%
US Dollar vs CAD
1.38351
0.00%
Bitcoin
87,368.96
-0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nyxoah SA (NYXH)

  7. Nyxoah SA (NYXH) News

NYXH

Nyxoah (NYXH)

Nyxoah SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NYXH
DateTimeSourceHeadlineSymbolCompany
04/16/20255:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
04/16/20251:00AMGlobeNewswire Inc.Conditional Issuance of SharesNASDAQ:NYXHNyxoah SA
04/08/20255:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
04/08/202512:00AMGlobeNewswire Inc.Nyxoah Provides Update on FDA Approvable Letter for Genio SystemNASDAQ:NYXHNyxoah SA
04/01/202511:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NYXHNyxoah SA
03/26/20255:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
03/26/20252:00AMGlobeNewswire Inc.FDA Issues Nyxoah an Approvable Letter for its Genio® SystemNASDAQ:NYXHNyxoah SA
03/20/20255:01PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:NYXHNyxoah SA
03/20/20253:26PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NYXHNyxoah SA
03/20/20253:05PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:NYXHNyxoah SA
03/13/20255:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
03/13/20251:00AMGlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
03/10/20254:05PMGlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025NASDAQ:NYXHNyxoah SA
03/03/20253:30PMGlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceNASDAQ:NYXHNyxoah SA
02/19/202512:05AMGlobeNewswire Inc.Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastNASDAQ:NYXHNyxoah SA
02/14/20251:31PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NYXHNyxoah SA
01/20/20253:30PMGlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
01/02/20253:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
12/20/20243:30PMGlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
12/13/20243:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
12/13/20241:05AMGlobeNewswire Inc.Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandNASDAQ:NYXHNyxoah SA
12/02/20243:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
11/27/20243:30PMGlobeNewswire Inc.Information on the total number of voting rights and sharesNASDAQ:NYXHNyxoah SA
11/20/20243:21PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
11/20/20243:05PMGlobeNewswire Inc.Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:NYXHNyxoah SA
11/19/202412:00AMGlobeNewswire Inc.Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024NASDAQ:NYXHNyxoah SA
11/18/20243:42PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
11/18/20243:30PMGlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
11/08/20243:44PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NYXHNyxoah SA
11/06/20243:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
 Showing the most relevant articles for your search:NASDAQ:NYXH

Your Recent History

BIT
UB3CVS
Unicredit Bank
AMEX
PHEQ
Parametric Hedged Equity...
DBI
I2CJ
XSP5SUE7HGBPINAV
TG
QCI
Qualcomm
LSE
FTCS
Ft Ftcs
BIT
P1R4V0
BNP Paribas Issuance
AMEX
DC.WS
Dakota Gold
OKEX
XTZBTC
Tezos
AMEX
SPHY
SPDR Portfolio High Yiel...
BIT
ACAPEM
AcomeA Emerging Class Q2...
DBI
I2UC
DAXsubsector Oil and Gas...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads